Repligen (RGEN) Income from Continuing Operations (2010 - 2026)
Repligen (RGEN) reported Income from Continuing Operations of 8333000.0 for Q1 2026, up 42.93% year-over-year from 5830000.0 in Q1 2025, and down 37.28% quarter-over-quarter from 13287000.0 in Q4 2025.
Repligen (RGEN) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Income from Continuing Operations data on file, last reported at 8333000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 8333000.0, up 42.93% year-over-year; the trailing twelve-month figure through Mar 2026 was 51398000.0 (up 230.0% YoY), and the FY2025 annual result was 48894000.0, up 216.22% from the prior year.
- Income from Continuing Operations declined to 8333000.0 in Q1 2026 per RGEN's latest filing, from 13287000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 49861000.0 in Q2 2022 and troughed at 104717000.0 in Q4 2022.
- A 5-year average of 6006058.82 and a median of 13287000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations slumped 2210.8% in 2024, then jumped 2380.12% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 104717000.0 in 2022, then jumped by 102.28% to 2389000.0 in 2023, then tumbled by 2210.8% to 50427000.0 in 2024, then soared by 126.35% to 13287000.0 in 2025, then slumped by 37.28% to 8333000.0 in 2026.
- Business Quant data shows RGEN's Income from Continuing Operations at 8333000.0 in Q1 2026, 13287000.0 in Q4 2025, and 14912000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 8.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.33 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | 14.87 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | -50.43 Mn |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 2.39 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 19.79 Mn |
| Mar 31, 2023 | 15.34 Mn |
| Dec 31, 2022 | -104.72 Mn |
| Sep 30, 2022 | 40.41 Mn |
| Jun 30, 2022 | 49.86 Mn |
| Mar 31, 2022 | 46.96 Mn |
| Dec 31, 2021 | -52.87 Mn |
| Sep 30, 2021 | 33.50 Mn |
| Jun 30, 2021 | 36.23 Mn |